Related Experiment Video

Updated: Sep 30, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.8K

The Impact of Waived Cost-Sharing Policy on COVID-19 Daily Testing and Deaths

Ahmed Almuqarrab1, Ayman Almuqamam2, Fatema Alhayki3

  • 1Respiratory Medicine, Pennsylvania State University College of Medicine, Hershey, USA.

Cureus
|March 16, 2022
PubMed

Insights

Waived cost-sharing for COVID-19 testing and treatment increased testing rates and decreased COVID-19 deaths in Michigan. This policy demonstrated a positive public health impact, reducing daily fatalities and boosting test utilization.

Area of Science:

  • Public Health
  • Health Economics
  • Epidemiology

Background:

  • Coronavirus disease 2019 (COVID-19) poses a significant global health threat.
  • Waived cost-sharing policies for preventative services are known to increase utilization, but their effect on COVID-19 outcomes is unclear.

Purpose of the Study:

  • To investigate the impact of waived cost-sharing policies on COVID-19 testing and mortality rates.
  • To compare outcomes in Michigan, which implemented a policy, with Illinois, which did not.

Main Methods:

  • A difference-in-differences approach was used to compare pre- and post-policy data.
  • Linear regression analysis assessed changes in COVID-19 tests and deaths.
  • Data were sourced from the Johns Hopkins University Coronavirus Resource Center.

Main Results:

  • Michigan saw a significant increase in daily COVID-19 tests by 51,350 post-policy.
  • Michigan experienced 50.19 fewer daily COVID-19 deaths compared to Illinois.
  • Michigan conducted 28,879 fewer tests daily than Illinois overall.

Conclusions:

  • Waived cost-sharing for COVID-19 testing and treatment positively influenced testing rates.
  • The policy was associated with a reduction in daily COVID-19-related deaths.
  • State-level policy interventions can effectively mitigate COVID-19's public health impact.

Keywords:
cost sharingcovid 19 testingcovid-19deductibles and coinsurancepandemics

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

551
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.2K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
187
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
13.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.2K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
452